BCDA
Biocardia Inc
NASDAQ: BCDA · HEALTHCARE · BIOTECHNOLOGY
$1.10
-3.51% today
Updated 2026-04-29
Market cap
$12.69M
P/E ratio
—
P/S ratio
2,520.59x
EPS (TTM)
$-1.23
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
Biocardia Inc (BCDA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-950.00%
ROA
-145.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-92804.00 | — | — | — |
| 2007 | $643000.00 | $-75444.00 | 79.78% | -12.41% | -11.73% |
| 2008 | $1.27M | $-5.80M | 84.46% | -444.16% | -457.41% |
| 2009 | $1.87M | $-5.08M | 79.67% | -272.98% | -271.70% |
| 2010 | — | $-11.51M | — | — | — |
| 2011 | $12000.00 | $9.66M | 100.00% | -5,150.00% | 80,516.67% |
| 2012 | $62000.00 | $305000.00 | 100.00% | -546.77% | 491.94% |
| 2013 | $268000.00 | $19000.00 | 100.00% | 3.36% | 7.09% |
| 2014 | $427000.00 | $234000.00 | 100.00% | 54.10% | 54.80% |
| 2015 | $517000.00 | $322000.00 | 100.00% | 61.70% | 62.28% |
| 2016 | $576000.00 | $-10.31M | -29.51% | -1,320.83% | -1,789.93% |
| 2017 | $479000.00 | $-12.31M | -44.05% | -2,589.77% | -2,569.52% |
| 2018 | $625000.00 | $-13.99M | 17.28% | -2,256.32% | -2,237.92% |
| 2019 | $710000.00 | $-14.71M | 49.58% | -2,001.83% | -2,071.69% |
| 2020 | $145000.00 | $-15.00M | 97.24% | -10,709.66% | -10,347.59% |
| 2021 | $1.01M | $-12.62M | 36.95% | -1,244.33% | -1,243.45% |
| 2022 | $1.35M | $-11.91M | -780.25% | -880.25% | -881.14% |
| 2023 | $477000.00 | $-11.57M | -1,519.71% | -2,441.09% | -2,425.79% |
| 2024 | $58000.00 | $-7.95M | -7,463.79% | -13,794.83% | -13,700.00% |
| 2025 | $0.00 | $-8.23M | — | — | — |